{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:01:03Z","timestamp":1790622063596,"version":"4.1.0"},"reference-count":43,"publisher":"JLE","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Dermatol"],"published-print":{"date-parts":[[2018,1,1]]},"DOI":"10.1684\/ejd.2017.3211","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T15:13:09Z","timestamp":1696864389000},"page":"13-25","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Overexpression of cytotoxic proteins correlates with liver function impairment in patients with drug reaction with eosinophilia and systemic symptoms (DRESS)"],"prefix":"10.1684","volume":"28","author":[{"given":"Fanping","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-an","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"18929","published-online":{"date-parts":[[2018,4,3]]},"reference":[{"key":"3211_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/cmi.2009.3","volume":"6","author":"L. Chavez-Galan","year":"2009","unstructured":"Chavez-Galan L, Arenas-Del Angel MC, Zenteno E, Ch\u00e1vez R, Lascurain R. Cell death mechanisms induced by cytotoxic lymphocytes. Cell Mol Immunol 2009; 6: 15\u201325.","journal-title":"Cell Mol Immunol"},{"key":"3211_CR2","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1097\/ACI.0b013e328355b865","volume":"12","author":"M. Tohyama","year":"2012","unstructured":"Tohyama M, Hashimoto K. Immunological mechanisms of epidermal damage in toxic epidermal necrolysis. Curr Opin Allergy Clin Immunol 2012; 12: 376\u201382.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"3211_CR3","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1111\/bjd.12501","volume":"169","author":"S.H. Kardaun","year":"2013","unstructured":"Kardaun SH, Sekula P, Valeyrie-Allanore L, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol 2013; 169: 1071\u201380.","journal-title":"Br J Dermatol"},{"key":"3211_CR4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/MD.0b013e3181a4d1a1","volume":"88","author":"M.M. Ben","year":"2009","unstructured":"Ben MM, Leclerc-Mercier S, Blanche P, et al. Drug-induced hypersensitivity syndrome: clinical and biologic disease patterns in 24 patients. Medicine (Baltimore) 2009; 88: 131\u201340.","journal-title":"Medicine (Baltimore)"},{"key":"3211_CR5","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jaad.2009.08.050","volume":"63","author":"C.C. Ang","year":"2010","unstructured":"Ang CC, Wang YS, Yoosuff EL, Tay YK. Retrospective analysis of drug-induced hypersensitivity syndrome: a study of 27 patients. J Am Acad Dermatol 2010; 63: 219\u201327.","journal-title":"J Am Acad Dermatol"},{"key":"3211_CR6","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.iac.2009.04.007","volume":"29","author":"Y. Kano","year":"2009","unstructured":"Kano Y, Shiohara T. The variable clinical picture of drug-induced hypersensitivity syndrome\/drug rash with eosinophilia and systemic symptoms in relation to the eliciting drug. Immunol Allergy Clin North Am 2009; 29: 481\u2013501.","journal-title":"Immunol Allergy Clin North Am"},{"key":"3211_CR7","doi-asserted-by":"publisher","first-page":"693e1","DOI":"10.1016\/j.jaad.2013.01.033","volume":"68","author":"Z. Husain","year":"2013","unstructured":"Husain Z, Reddy BY, Schwartz RA. DRESS syndrome: Part I. Clinical perspectives. J Am Acad Dermatol 2013; 68: 693e1\u20137014e, quiz: 706-8.","journal-title":"J Am Acad Dermatol"},{"key":"3211_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2332\/allergolint.55.1","volume":"55","author":"T. Shiohara","year":"2006","unstructured":"Shiohara T, Inaoka M, Kano Y. Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses. Allergol Int 2006; 55: 1\u20138.","journal-title":"Allergol Int"},{"key":"3211_CR9","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/bjd.13683","volume":"173","author":"N. Ortonne","year":"2015","unstructured":"Ortonne N, Valeyrie-Allanore L, Bastuji-Garin S, et al. Histopathology of drug rash with eosinophilia and systemic symptoms syndrome: a morphological and phenotypical study. Brit J Dermatol 2015; 173: 50\u20138.","journal-title":"Brit J Dermatol"},{"key":"3211_CR10","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1038\/nm.1884","volume":"14","author":"W.H. Chung","year":"2008","unstructured":"Chung WH, Hung SI, Yang JY, et al. Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis. Nat Med 2008; 14: 1343\u201350.","journal-title":"Nat Med"},{"key":"3211_CR11","doi-asserted-by":"publisher","first-page":"514","DOI":"10.7326\/0003-4819-151-7-200910060-00016","volume":"151","author":"R. Abe","year":"2009","unstructured":"Abe R, Yoshioka N, Murata J, Fujita Y, Shimizu H. Granulysin as a marker for early diagnosis of the Stevens-Johnson syndrome. Ann Intern Med 2009; 151: 514\u20135.","journal-title":"Ann Intern Med"},{"key":"3211_CR12","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1126\/science.282.5388.490","volume":"282","author":"I. Viard","year":"1998","unstructured":"Viard I, Wehrli P, Bullani R, et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 1998; 282: 490\u20133.","journal-title":"Science"},{"key":"3211_CR13","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/S0002-9440(10)64284-8","volume":"162","author":"R. Abe","year":"2003","unstructured":"Abe R, Yoshioka N, Murata J, Fujita Y, Shimizu H. Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand. Am J Pathol 2003; 162: 1515\u201320.","journal-title":"Am J Pathol"},{"key":"3211_CR14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1067\/mai.2002.120563","volume":"109","author":"S.J. Posadas","year":"2002","unstructured":"Posadas SJ, Padial A, Torres MJ, et al. Delayed reactions to drugs show levels of perforin granzyme B and Fas-L to be related to disease severity. J Allergy Clin Immunol 2002; 109: 155\u201361.","journal-title":"J Allergy Clin Immunol"},{"key":"3211_CR15","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3390\/toxins6010194","volume":"6","author":"S.C. Su","year":"2014","unstructured":"Su SC, Chung WH. Cytotoxic proteins and therapeutic targets in severe cutaneous adverse reactions. Toxins (Basel) 2014; 6: 194\u2013210.","journal-title":"Toxins (Basel)"},{"key":"3211_CR16","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/S1085-5629(96)80038-1","volume":"15","author":"H. Bocquet","year":"1996","unstructured":"Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin Cutan Med Surg 1996; 15: 250\u20137.","journal-title":"Semin Cutan Med Surg"},{"key":"3211_CR17","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/j.1365-2133.2006.07284.x","volume":"155","author":"H. Peyriere","year":"2006","unstructured":"Peyriere H, Dereure O, Breton H, et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol 2006; 155: 422\u20138.","journal-title":"Br J Dermatol"},{"key":"3211_CR18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.tox.2004.12.022","volume":"209","author":"J.C. Roujeau","year":"2005","unstructured":"Roujeau JC. Clinical heterogeneity of drug hypersensitivity. Toxicology 2005; 209: 123\u20139.","journal-title":"Toxicology"},{"key":"3211_CR19","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","volume":"331","author":"J.C. Roujeau","year":"1994","unstructured":"Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994; 331: 1272\u201385.","journal-title":"N Engl J Med"},{"key":"3211_CR20","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/clpt.2009.252","volume":"88","author":"B. Sassolas","year":"2010","unstructured":"Sassolas B, Haddad C, Mockenhaupt M, et al. ALDEN an algorithm for assessment of drug causality in Stevens-Johnson syndrome and toxic epidermal necrolysis: comparison with case-control analysis. J Clin Pharmacol Ther 2010; 88: 60\u20138.","journal-title":"J Clin Pharmacol Ther"},{"key":"3211_CR21","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","volume":"129","author":"S. Bastuji-Garin","year":"1993","unstructured":"Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC. Clinical classification of cases of toxic epidermal necrolysis Stevens-Johnson syndrome and erythema multiforme. Arch Dermatol 1993; 129: 92\u20136.","journal-title":"Arch Dermatol"},{"key":"3211_CR22","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.2217\/pgs.14.69","volume":"15","author":"F. Yang","year":"2014","unstructured":"Yang F, Gu B, Zhang L, et al. HLA-B*13:01 is associated with salazosulfapyridine-induced drug rash with eosinophilia and systemic symptoms in Chinese Han population. Pharmacogenomics 2014; 15: 1461\u20139.","journal-title":"Pharmacogenomics"},{"key":"3211_CR23","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.2217\/pgs.12.89","volume":"13","author":"Z.H. Cao","year":"2012","unstructured":"Cao ZH, Wei ZY, Zhu QY, et al. HLA-B*58:01 allele is associated with augmented risk for both mild and severe cutaneous adverse reactions induced by allopurinol in Han Chinese. Pharmacogenomics 2012; 13: 1193\u2013201.","journal-title":"Pharmacogenomics"},{"key":"3211_CR24","doi-asserted-by":"publisher","first-page":"4134","DOI":"10.1073\/pnas.0409500102","volume":"102","author":"S.I. Hung","year":"2005","unstructured":"Hung SI, Chung WH, Liou LB, et al. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci USA 2005; 102: 4134\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3211_CR25","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1111\/j.1365-2133.2007.08167.x","volume":"157","author":"M. Tohyama","year":"2007","unstructured":"Tohyama M, Hashimoto K, Yasukawa M, et al. Association of human herpesvirus 6 reactivation with the flaring and severity of druginduced hypersensitivity syndrome. Br J Dermatol 2007; 157: 934\u201340.","journal-title":"Br J Dermatol"},{"key":"3211_CR26","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/j.1365-2133.2006.07332.x","volume":"155","author":"M. Seishima","year":"2006","unstructured":"Seishima M, Yamanaka S, Fujisawa T, Tohyama M, Hashimoto K. Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome. Br J Dermatol 2006; 155: 344\u20139.","journal-title":"Br J Dermatol"},{"key":"3211_CR27","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.iac.2004.03.012","volume":"24","author":"W.J. Pichler","year":"2004","unstructured":"Pichler WJ. Immune mechanism of drug hypersensitivity. Immunol Allergy Clin North Am 2004; 24: 373\u201397.","journal-title":"Immunol Allergy Clin North Am"},{"key":"3211_CR28","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1126\/scitranslmed.3001116","volume":"2","author":"D. Picard","year":"2010","unstructured":"Picard D, Janela B, Descamps V, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response. Sci Transl Med 2010; 2: 46 ra62.","journal-title":"Sci Transl Med"},{"key":"3211_CR29","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/j.1365-2133.2012.10921.x","volume":"167","author":"N. Saito","year":"2012","unstructured":"Saito N, Abe R, Yoshioka N, Murata J, Fujita Y, Shimizu H. Prolonged elevation of serum granulysin in drug-induced hypersensitivity syndrome. Br J Dermatol 2012; 167: 452\u20133.","journal-title":"Br J Dermatol"},{"key":"3211_CR30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0092-8674(95)90365-8","volume":"81","author":"G. Berke","year":"1995","unstructured":"Berke G. The CTL\u2019s kiss of death. Cell 1995; 81: 9\u201312.","journal-title":"Cell"},{"key":"3211_CR31","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1097\/01.all.0000235898.80052.80","volume":"6","author":"J.V. Castell","year":"2006","unstructured":"Castell JV, Castell M. Allergic hepatitis induced by drugs. Curr Opin Allergy Clin Immunol 2006; 6: 258\u201365.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"3211_CR32","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1080\/01926230590522365","volume":"33","author":"G.A. Parker","year":"2005","unstructured":"Parker GA, Picut CA. Liver immunobiology. Toxicol Pathol 2005; 33: 52\u201362.","journal-title":"Toxicol Pathol"},{"key":"3211_CR33","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/DAD.0000000000000439","volume":"38","author":"M.M. Goncalo","year":"2016","unstructured":"Goncalo MM, Cardoso JC, Gouveia MP, et al. Histopathology of the exanthema in DRESS is not specific but may indicate severity of systemic involvement. J Am J Dermatopathol 2016; 38: 423\u201333.","journal-title":"J Am J Dermatopathol"},{"key":"3211_CR34","first-page":"391","volume":"168","author":"S. Walsh","year":"2013","unstructured":"Walsh S, Diaz-Cano S, Higgins E, et al. Drug reaction with eosinophilia and systemic symptoms: is cutaneous phenotype a prognostic marker for outcome? A review of clinicopathological features of 27 cases. Br J Dermatol 2013; 168: 391\u2013401.","journal-title":"A review of clinicopathological features of 27 cases. Br J Dermatol"},{"key":"3211_CR35","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1159\/000069956","volume":"206","author":"S. Tas","year":"2003","unstructured":"Tas S, Simonart T. Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): an update. Dermatology 2003; 206: 353\u20136.","journal-title":"Dermatology"},{"key":"3211_CR36","doi-asserted-by":"publisher","first-page":"100","DOI":"10.2340\/00015555-1168","volume":"92","author":"Y. Kito","year":"2012","unstructured":"Kito Y, Ito T, Tokura Y, Hashizume H. High-dose intravenous immunoglobulin monotherapy for drug-induced hypersensitivity syndrome. Acta Derm Venereol 2012; 92: 100\u20131.","journal-title":"Acta Derm Venereol"},{"key":"3211_CR37","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jaip.2013.11.008","volume":"2","author":"V.R. Galvao","year":"2014","unstructured":"Galvao VR, Aun MV, Kalil J, Castells M, Giavina-Bianchi P. Clinical and laboratory improvement after intravenous immunoglobulin in drug reaction with eosinophilia and systemic symptoms. J Allergy Clin Immunol Pract 2014; 2: 107\u201310.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"3211_CR38","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1046\/j.1365-2222.2000.00847.x","volume":"30","author":"N. Yawalkar","year":"2000","unstructured":"Yawalkar N, Egli F, Hari Y, Nievergelt H, Braathen LR, Pichler WJ. Infiltration of cytotoxic T cells in drug-induced cutaneous eruptions. Clin Exp Allergy 2000; 30: 847\u201355.","journal-title":"Clin Exp Allergy"},{"key":"3211_CR39","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.jaci.2004.07.047","volume":"114","author":"A. Nassif","year":"2004","unstructured":"Nassif A, Bensussan A, Boumsell L, et al. Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells. J Allergy Clin Immunol 2004; 114: 1209\u201315.","journal-title":"J Allergy Clin Immunol"},{"key":"3211_CR40","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1126\/science.282.5388.490","volume":"282","author":"I. Viard","year":"1998","unstructured":"Viard I, Wehrli P, Bullani R, et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 1998; 282: 490\u20133.","journal-title":"Science"},{"key":"3211_CR41","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1038\/nm.1884","volume":"14","author":"W.H. Chung","year":"2008","unstructured":"Chung WH, Hung SI, Yang JY, et al. Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis. Nat Med 2008; 14: 1343\u201350.","journal-title":"Nat Med"},{"key":"3211_CR42","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.jaci.2008.06.013","volume":"122","author":"J. Murata","year":"2008","unstructured":"Murata J, Abe R, Shimizu H. Increased soluble Fas ligand levels in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis preceding skin detachment. J Allergy Clin Immunol 2008; 122: 992\u20131000.","journal-title":"J Allergy Clin Immunol"},{"key":"3211_CR43","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/tpj.2015.25","volume":"16","author":"F. Yang","year":"2016","unstructured":"Yang F, Xuan J, Chen J, et al. HLA-B*59:01: a marker for Stevens-Johnson syndrome\/toxic epidermal necrolysis caused by methazolamide in Han Chinese. Pharmacogenomics J 2016; 16: 83\u20137.","journal-title":"Pharmacogenomics J"}],"container-title":["European Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1684\/ejd.2017.3211.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1684\/ejd.2017.3211\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1684\/ejd.2017.3211.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.jle.com\/10.1684\/ejd.2017.3211","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:17:01Z","timestamp":1741191421000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jle.com\/10.1684\/ejd.2017.3211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1,1]]}},"alternative-id":["3211"],"URL":"https:\/\/doi.org\/10.1684\/ejd.2017.3211","relation":{},"ISSN":["1952-4013"],"issn-type":[{"value":"1952-4013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,1]]},"assertion":[{"value":"20 Juli 2017","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2018","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}